Neurology
RSSArticles
-
For Migraine Pain, Green Light May Give Relief
Migraine-related photophobia appears to originate in cone-driven retinal pathways and is then mediated by thalamic neurons. Green light causes less stimulation than other colors.
-
Guillain-Barré Syndrome in the Elderly
Guillain-Barré syndrome in the very old (> 80 years of age) results in more severe disease with poorer recovery.
-
Is This ECG Normal for Age?
The seemingly tall lateral chest lead R waves are not outside the normal range for a child this age.
-
Clinical Briefs
In this section: effects of testosterone treatment in older men; liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis; and long-acting anticholinergics and beta agonists for COPD.
-
Daclizumab Injection (Zinbryta)
Another option for the treatment of the relapsing form of multiple sclerosis.
-
The Current Outlook for Cardiac Tamponade
In the modern era, cardiac tamponade is most commonly caused by malignancies with poor prognosis. As compared to older literature, iatrogenic causes have increased, most resulting from complications of percutaneous coronary intervention.
-
Nature Nurturing Health
A national prospective cohort study of nurses found that higher levels of green vegetation were associated with decreased mortality.
-
The Relationship Between Inactivity and Mortality in Heart Failure Patients
Physical inactivity in heart failure patients was associated with an increased risk of all-cause death and cardiac death but not with an increased risk of heart failure hospitalization.
-
Acetazolamide in Mechanically Ventilated Patients with COPD: Is There a Benefit?
Compared to placebo, the use of acetazolamide in mechanically ventilated patients with COPD does not significantly reduce the duration of mechanical ventilation. -
New Analysis of COGENT Data Supports Proton Pump Inhibitor Benefit with Low and High Aspirin Doses
A dedicated analysis of the COGENT trial involving coronary artery disease patients on dual antiplatelet therapy shows comparable risks of gastrointestinal and cardiovascular events between low- and high-dose aspirin, and similar benefits of prophylactic proton pump inhibitor therapy.